Intrexon reported $-0.1 in EPS Earnings Per Share for its fiscal quarter ending in June of 2024.





Eps Change Date
Agenus USD 1.02 1.32 Mar/2026
Alaunos Therapeutics USD -0.52 0.02 Mar/2026
Amgen USD 6.29 1.14 Jun/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD -1.36 0.43 Jun/2026
AstraZeneca USD 2.63 0.05 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Gilead Sciences USD -6.75 8.78 Jun/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Incyte USD 3.09 1.28 Jun/2026
Intrexon USD -0.1 0.03 Jun/2024
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
Ligand Pharmaceuticals USD 2.37 0.74 Jun/2026
MacroGenics USD -0.58 0.36 Mar/2026
MannKind USD -0.01 0.01 Jun/2026
Merck USD -0.13 1.15 Jun/2026
Novartis USD 2.41 0.42 Jun/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Roche Holding CHF 10.98 2.61 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Thermo Fisher Scientific USD 6.03 0.59 Jun/2026
Veracyte USD 0.54 0.02 Jun/2026
Xencor USD -0.29 1.42 Jun/2026